Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil.
Long-acting insulin analogues for type 1 diabetes (T1D) treatment have been available on the Brazilian market since 2002. However, the population cannot access the analogues through the public health system.To estimate the incremental budget impact of long-acting insulin analogues coverage for T1D p...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5132224?pdf=render |